Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort.

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Abstract Text:

STUDY OBJECTIVES: To examine the relationship between sleep-disordered breathing (SDB) and cardiovascular disease among community-dwelling older adults. Previous studies have suggested relatively stronger associations between SDB and such morbidity in middle-aged, relative to elderly, populations. DESIGN: Cross-sectional analysis of an elderly ambulatory, non-clinic-based cohort (Bay Area Sleep Cohort, BASC) SETTING: Community population studied in a sleep laboratory PARTICIPANTS: One hundred twenty-nine older adults (mean [+/- SD] age = 72.6 [8.3]) (78 women; 51 men). INTERVENTIONS: NA. MEASUREMENTS: Complete clinical history including list of current medications, physical examination, selected blood chemistries, multiple blood pressure measurements, 12-lead electrocardiogram, and 2 consecutive nights of polysomnography. RESULTS: Fifty-one individuals (40%) were taking 1 or more cardiovascular medications and 24 (19%) had an apnea-hypopnea index (AHI) of 10 or more per hour of sleep. Cardiovascular medication use was related to cardiac events or procedures, history of angina, higher systolic or diastolic blood pressure, and abnormal electrocardiogram. Logistic regression showed statistically significant association between cardiovascular medication use and AHI of 10 or greater per hour, independent of age, sex, and body mass index. Supplementary analyses indicated that rapid eye movement AHI of 10 or greater per hour was significantly associated with elevated diastolic blood pressure. CONCLUSIONS: The results suggest that sleep-disordered breathing may contribute to increased cardiovascular morbidity in older adults.

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Sleep

VOLUME: 31

Page Numbers: 563-8

Journal Abbreviation:

ISSN: 0161-8105

DAY: 1

MONTH: Apr

YEAR: 2008

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7809084

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort.

AFFILIATION: Division of Geriatrics & Gerontology, Emory University School of Medicine, Atlanta, GA 30329, USA. yendesh@emory.edu

Country: United States

AGENCY: United States NIA

GRANT: R01 AG-06066

ACRONYM: AG

MEDLINETA: Sleep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort Related Publications

• Association of sleep difficulty with Kidney Disease Quality of Life cognitive function score reported by patients who recently started dialysis.
• Effects of moderate-intensity exercise on polysomnographic and subjective sleep quality in older adults with mild to moderate sleep complaints.
• Is sleep apnea a cause of reversible dementia in old age?
• Patient-reported sleep difficulty and cognitive function during the first year of dialysis.
• Polysomnographic and clinical correlates of behaviorally observed daytime sleep in nursing home residents.
• Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64-99 years.
• Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort.
• Sleep-disordered breathing and nocturia in older adults.
• Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.